| Prepro-Nerve Growth Factor (99-115) (mouse) | C89H139N27O26 | 2003.25 | H-Pro-Glu-Ala-His-Trp-Thr-Lys-Leu-Gln-His-Ser-Leu-Asp-Thr-Ala-Leu-Arg-OH | |
| Nociceptin, Orphanin FQ | C79H129N27O22 | 1809.06 | 170713-75-4 | H-Phe-Gly-Gly-Phe-Thr-Gly-Ala-Arg-Lys-Ser-Ala-Arg-Lys-Leu-Ala-Asn-Gln-OH Trifluoroacetate salt |
| Nociceptin (1-13) amide Orphanin FQ (1-13) amide |
C61H100N22O15 | 1381.60 | 178064-02-3 | H-Phe-Gly-Gly-Phe-Thr-Gly-Ala-Arg-Lys-Ser-Ala-Arg-Lys-NH2 Trifluoroacetate salt |
| C44H70N14O9 | 939.13 | 200959-48-4 | Ac-Arg-Tyr-Tyr-Arg-Ile-Lys-NH2 | |
| C22H26N4O5 | 426.47 | 40204-87-3 | H-Phe-Gly-Gly-Phe-OH | |
| Obestatin (human) | C116H176N32O33 | 2546.87 | 1081110-72-6 | H-Phe-Asn-Ala-Pro-Phe-Asp-Val-Gly-Ile-Lys-Leu-Ser-Gly-Val-Gln-Tyr-Gln-Gln-His-Ser-Gln-Ala-Leu-NH2 |
| Biotinyl-Obestatin (human) | C126H190N34O35S | 2773.17 | Biotinyl-Phe-Asn-Ala-Pro-Phe-Asp-Val-Gly-Ile-Lys-Leu-Ser-Gly-Val-Gln-Tyr-Gln-Gln-His-Ser-Gln-Ala-Leu-NH2 | |
| Obestatin (rat) | C114H174N34O31 | 2516.85 | 869705-22-6 | H-Phe-Asn-Ala-Pro-Phe-Asp-Val-Gly-Ile-Lys-Leu-Ser-Gly-Ala-Gln-Tyr-Gln-Gln-His-Gly-Arg-Ala-Leu-NH2 |
| Biotinyl-Obestatin (rat) | C124H188N36O33S | 2743.15 | Biotinyl-Phe-Asn-Ala-Pro-Phe-Asp-Val-Gly-Ile-Lys-Leu-Ser-Gly-Ala-Gln-Tyr-Gln-Gln-His-Gly-Arg-Ala-Leu-NH2 | |
| DOTA-(Tyr3)-Octreotate DOTATATE, DOTA-(Tyr3,Thr8)-Octreotide |
C65H90N14O19S2 | 1435.65 | 177943-89-4 | 4,7,10-Tricarboxymethyl-1,4,7,10-tetraaza-cyclododecan-1-yl-acetyl-D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Thr-OH (Disulfide bond) |
| Octreotide, (D-Phe5,Cys6·11,D-Trp8,L-Threoninol12)-Somatostatin-14 (5-12), SMS-201-995 | C49H66N10O10S2 | 1019.26 | 79517-01-4/83150-76-9 | H-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-L-threoninol (Disulfide bond) |
| H-Tyr-L-1,2,3,4-tetrahydroisoquinoline-3-carboxamide · HCl | C19H21N3O3 | 375.86 | 154121-70-7 | H-Tyr-Tic-NH2 |
| H-Tyr-D-1,2,3,4-tetrahydroisoquinoline-3-carboxamide · HCl | C19H21N3O3 | 375.86 | 154265-38-0 | H-Tyr-D-Tic-NH2 |
| TIPP | C37H38N4O6 | 634.73 | 146369-65-5 | H-Tyr-Tic-Phe-Phe-OH |
| Hypocretin (70-98) (human), Orexin B-Gly (human) | C125H214N44O37S | 2957.41 | H-Arg-Ser-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Ala-Ser-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-Gly-OH | |
| Orexin A (human, bovine, canine, mouse, ovine, porcine, rat) Hypocretin-1 (human, bovine, canine, mouse, ovine, porcine, rat) |
C152H243N47O44S4 | 3561.16 | 205640-90-0 | Pyr-Pro-Leu-Pro-Asp-Cys-Cys-Arg-Gln-Lys-Thr-Cys-Ser-Cys-Arg-Leu-Tyr-Glu-Leu-Leu-His-Gly-Ala-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Leu-NH2 (Disulfide bonds between Cys⁶ and Cys¹²/Cys⁷ and Cys¹⁴) |
| Orexin B (human), Hypocretin-2 (human) | C123H212N44O35S | 2899.38 | 205640-91-1 | H-Arg-Ser-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Ala-Ser-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-NH2 Trifluoroacetate salt |
| (Ala11,D-Leu15)-Orexin B (human) | C120H206N44O35S | 2857.30 | 532932-99-3 | H-Arg-Ser-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Ala-Gln-Arg-Leu-D-Leu-Gln-Ala-Ser-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-NH2 |
| Orexin B (mouse, rat), Hypocretin-2 (mouse, rat) | C126H215N45O34S | 2936.44 | 202801-92-1 | H-Arg-Pro-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Ala-Asn-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-NH2 |
| Orphan GPCR SP9155 Agonist P518 (human) P518 (human), Orphan G-Protein Coupled Receptor SP9155 Agonist Peptide P518 (human) |
C127H195N37O37 | 2832.17 | 600171-68-4 | H-Thr-Ser-Gly-Pro-Leu-Gly-Asn-Leu-Ala-Glu-Glu-Leu-Asn-Gly-Tyr-Ser-Arg-Lys-Lys-Gly-Gly-Phe-Ser-Phe-Arg-Phe-NH2 Trifluoroacetate salt |
| Orphan GPCR SP9155 Agonist P550 (mouse) Orphan G-Protein Coupled Receptor SP9155 Agonist Peptide P550 (mouse), P550 (mouse) |
C126H195N37O37 | 2820.16 | 600171-70-8 | H-Ala-Ser-Gly-Pro-Leu-Gly-Thr-Leu-Ala-Glu-Glu-Leu-Ser-Ser-Tyr-Ser-Arg-Arg-Lys-Gly-Gly-Phe-Ser-Phe-Arg-Phe-NH2 Trifluoroacetate salt |
| (Glu13·17·20)-Osteocalcin (1-46) (mouse) | C226H351N57O74S2 | 5114.75 | H-Tyr-Leu-Gly-Ala-Ser-Val-Pro-Ser-Pro-Asp-Pro-Leu-Glu-Pro-Thr-Arg-Glu-Gln-Cys-Glu-Leu-Asn-Pro-Ala-Cys-Asp-Glu-Leu-Ser-Asp-Gln-Tyr-Gly-Leu-Lys-Thr-Ala-Tyr-Lys-Arg-Ile-Tyr-Gly-Ile-Thr-Ile-OH (Disulfide bond) | |
| 6-FAM-(Glu13·17·20)-Osteocalcin (1-46) (mouse) | C247H361N57O80S2 | 5473.05 | Fluorescein-6-carbonyl-Tyr-Leu-Gly-Ala-Ser-Val-Pro-Ser-Pro-Asp-Pro-Leu-Glu-Pro-Thr-Arg-Glu-Gln-Cys-Glu-Leu-Asn-Pro-Ala-Cys-Asp-Glu-Leu-Ser-Asp-Gln-Tyr-Gly-Leu-Lys-Thr-Ala-Tyr-Lys-Arg-Ile-Tyr-Gly-Ile-Thr-Ile-OH (Disulfide bond) | |
| Osteocalcin (1-49) (human) | C269H381N67O82S2 | 5929.52 | 136461-80-8 | H-Tyr-Leu-Tyr-Gln-Trp-Leu-Gly-Ala-Pro-Val-Pro-Tyr-Pro-Asp-Pro-Leu-Gla-Pro-Arg-Arg-Gla-Val-Cys-Gla-Leu-Asn-Pro-Asp-Cys-Asp-Glu-Leu-Ala-Asp-His-Ile-Gly-Phe-Gln-Glu-Ala-Tyr-Arg-Arg-Phe-Tyr-Gly-Pro-Val-OH (Disulfide bond) |
| Osteocalcin (7-19) (human) | C65H98N16O19 | 1407.59 | 120944-72-1 | H-Gly-Ala-Pro-Val-Pro-Tyr-Pro-Asp-Pro-Leu-Glu-Pro-Arg-OH |
| Osteocalcin (37-49) (human) | C75H104N20O19 | 1589.77 | 89458-24-2 | H-Gly-Phe-Gln-Glu-Ala-Tyr-Arg-Arg-Phe-Tyr-Gly-Pro-Val-OH |
| (Tyr38,Phe42·46)-Osteocalcin (38-49) (human) | C73H101N19O17 | 1516.72 | 129356-77-0 | H-Tyr-Gln-Glu-Ala-Phe-Arg-Arg-Phe-Phe-Gly-Pro-Val-OH |
| Osteocalcin (45-49) (human) | C30H39N5O7 | 581.67 | 85679-70-5 | H-Phe-Tyr-Gly-Pro-Val-OH |
| (Thr46)-Osteocalcin (45-49) (human) | C25H37N5O7 | 519.60 | 352279-02-8 | H-Phe-Thr-Gly-Pro-Val-OH |
| Osteogenic Growth Peptide OGP |
C68H110N22O18 | 1523.76 | 132996-61-3 | H-Ala-Leu-Lys-Arg-Gln-Gly-Arg-Thr-Leu-Tyr-Gly-Phe-Gly-Gly-OH |
